MedPath
FDA Approval

Everolimus

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 31, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Everolimus(10 mg in 1 1)

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Everolimus

Product Details

NDC Product Code
0093-7769
Application Number
ANDA210050
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 23, 2023
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171KClass: IACT
Code: 9HW64Q8G6GClass: ACTIBQuantity: 10 mg in 1 1
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
HYPROMELLOSE 2910 (3 MPA.S)Inactive
Code: 0VUT3PMY82Class: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Everolimus

Product Details

NDC Product Code
0093-7768
Application Number
ANDA210050
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 23, 2023
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171KClass: IACT
Code: 9HW64Q8G6GClass: ACTIBQuantity: 7.5 mg in 1 1
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
HYPROMELLOSE 2910 (3 MPA.S)Inactive
Code: 0VUT3PMY82Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Everolimus

Product Details

NDC Product Code
0093-7766
Application Number
ANDA210050
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 23, 2023
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
Code: 9HW64Q8G6GClass: ACTIBQuantity: 2.5 mg in 1 1
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171KClass: IACT
HYPROMELLOSE 2910 (3 MPA.S)Inactive
Code: 0VUT3PMY82Class: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

Everolimus

Product Details

NDC Product Code
0093-7767
Application Number
ANDA210050
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 23, 2023
Code: 9HW64Q8G6GClass: ACTIBQuantity: 5 mg in 1 1
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171KClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
HYPROMELLOSE 2910 (3 MPA.S)Inactive
Code: 0VUT3PMY82Class: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath